Cardiovascular Systems, Inc. develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee. It also provides Diamondback 360 Coronary orbital atherectomy systems, a coronary artery disease (CAD) product.
Market Cap | 843.961 Million | Shares Outstanding | 42.198 Million | Avg 30-day Volume | 584.414 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.2 |
Price to Revenue | 2.2524 | Debt to Equity | 0.0 | EBITDA | -33.765 Million |
Price to Book Value | 2.2567 | Operating Margin | -16.078 | Enterprise Value | 366.182 Million |
Current Ratio | 6.038 | EPS Growth | 0 | Quick Ratio | 4.685 |
1 Yr BETA | 0.7548 | 52-week High/Low | 20.57 / 12.26 | Profit Margin | -15.7882 |
Operating Cash Flow Growth | -129.0057 | Altman Z-Score | 3.5765 | Free Cash Flow to Firm | -39.027 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
WARD SCOTT R. CHAIRMAN AND CEO |
|
0 | 2023-04-27 | 5 |
|
0 | 2023-04-27 | 2 | |
|
0 | 2023-04-27 | 3 | |
|
0 | 2023-04-27 | 2 | |
ROSENSTEIN ALEXANDER GENERAL COUNSEL & CORP. SEC. |
|
0 | 2023-04-27 | 5 |
SEDO SANDRA CHIEF COMPLIANCE OFFICER |
|
0 | 2023-04-27 | 6 |
POINTS JEFFREY S. CHIEF FINANCIAL OFFICER |
|
0 | 2023-04-27 | 5 |
|
0 | 2023-04-27 | 2 | |
|
0 | 2023-04-27 | 2 | |
REMPE STEPHEN J. CHIEF HUMAN RESOURCES OFFICER |
|
0 | 2023-04-27 | 5 |
|
0 | 2023-04-27 | 2 | |
HASTINGS JOHN M. VP MANUFACTURING & OPERATIONS |
|
53,652 | 2022-08-12 | 1 |
|
15,658 | 2022-08-05 | 1 | |
EGELAND RYAN CHIEF MEDICAL OFFICER |
|
76,180 | 2022-02-08 | 0 |
WHITESCARVER DAVID VP OF CORP. DEV. AND IP |
|
63,264 | 2022-02-08 | 0 |
ROBB RHONDA J. CHIEF OPERATING OFFICER |
|
169,581 | 2022-02-07 | 0 |
|
202,076 | 2021-08-09 | 0 | |
|
94,332 | 2019-09-03 | 0 | |
GILLUND LAURA CHIEF TALENT OFFICER |
|
104,197 | 2018-08-28 | 0 |
|
1,699 | 2018-08-28 | 0 | |
BETTERLEY LAURENCE L CHIEF FINANCIAL OFFICER |
|
235,983 | 2017-08-15 | 0 |
KENNY KEVIN J. CHIEF OPERATING OFFICER |
|
151,280 | 2017-08-15 | 0 |
KOEHN PAUL A. SVP MANUFACTURING & OPERATIONS |
|
83,989 | 2017-05-31 | 0 |
|
17,282 | 2016-11-18 | 0 | |
|
No longer subject to file | 2016-09-19 | 0 | |
MARTIN DAVID PRESIDENT AND CEO |
|
481,607 | 2015-10-08 | 0 |
THATCHER ROBERT J. CHIEF HEALTHCARE POLICY OFF'R |
|
126,978 | 2015-10-02 | 0 |
|
1,399,345 | 2014-08-11 | 0 | |
FLAHERTY JAMES E CHIEF ADMINISTRATIVE OFFICER |
|
114,177 | 2014-05-01 | 0 |
|
701,687 | 2013-11-07 | 0 | |
|
2,027,658 | 2012-07-17 | 0 | |
|
116,888 | 2011-08-08 | 0 | |
KRAUS SCOTT WILLIAM VP SALES |
|
63,871 | 2011-07-19 | 0 |
DOUGHTY BRIAN VP OF COMMERICAL OPERATIONS |
|
58,914 | 2011-05-12 | 0 |
|
No longer subject to file | 2010-11-30 | 0 | |
TYSKA PAUL A VP OF BUSINESS DEV |
|
46,821 | 2010-08-13 | 0 |
|
0 | 2010-08-13 | 0 | |
|
255,036 | 2009-12-02 | 0 | |
|
No longer subject to file | 2009-02-25 | 0 | |
|
No longer subject to file | 2009-02-25 | 0 | |
|
No longer subject to file | 2009-02-25 | 0 | |
|
0 | 2008-12-31 | 0 | |
MITSUI & CO. VENTURE PARTNERS II, L.P. MITSUI & CO. VENTURE PARTNERS, INC. PRESIDENT AND CEO MITSUI & CO LTD GENERAL MANAGER |
|
0 | 2008-12-29 | 0 |
|
0 | 2008-12-29 | 0 | |
|
0 | 2008-12-29 | 0 | |
KALLOK MICHAEL J CHIEF SCIENTIFIC OFFICER |
|
5,500 | 2008-12-29 | 0 |
BORRELL JOHN R VP OF SALES |
|
23,000 | 2008-12-29 | 0 |
|
1,539,931 | 2008-12-12 | 0 | |
MORRISSEY DONALD J JR SR. VP, CORPORATE DEVELOPMENT |
|
70,258 | 2008-12-04 | 0 |
|
0 | 2008-05-08 | 0 | |
ECHOLS ROGER CHIEF MEDICAL OFFICER |
|
46,957 | 2007-11-01 | 0 |
LETENDRE PETER CHIEF COMMERCIAL OFFICER |
|
6,179 | 2007-06-29 | 0 |
|
8,156 | 2007-05-10 | 0 | |
WENDT HENRY |
|
1,052,983 | 2007-03-08 | 0 |
SMITH MARK L CFO AND TREASURER |
|
90,000 | 2007-03-08 | 0 |
JANJIC NEBOJSA CHIEF SCIENTIFIC OFFICER, SEC. |
|
90,000 | 2007-03-08 | 0 |
COLLINS KENNETH J PRESIDENT AND CEO |
|
100,000 | 2007-03-08 | 0 |
|
3,612,362 | 2006-07-03 | 0 | |
|
16,313 | 2006-06-28 | 0 | |
|
0 | 2006-06-27 | 0 | |
|
0 | 2006-06-27 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-04-27 16:32:08 -0400 | 2023-04-27 | D | 34,297 | d | 0 | direct | ||||||||||
2023-04-27 16:35:24 -0400 | 2023-04-27 | D | 16,734 | d | 0 | direct | ||||||||||
2023-04-27 16:32:28 -0400 | 2023-04-27 | D | 107,700 | $20.00 | d | 40,973 | direct | |||||||||
2023-04-27 16:32:28 -0400 | 2023-04-27 | D | 40,973 | $20.00 | d | 0 | direct | |||||||||
2023-04-27 16:33:46 -0400 | 2023-04-27 | D | 40,553 | d | 0 | direct | ||||||||||
2023-04-27 16:33:46 -0400 | 2023-04-27 | D | 9,449 | $20.00 | d | 0 | direct | |||||||||
2023-04-27 16:37:02 -0400 | 2023-04-27 | D | 138,957 | $20.00 | d | 34,051 | direct | |||||||||
2023-04-27 16:37:02 -0400 | 2023-04-27 | D | 34,051 | $20.00 | d | 0 | direct | |||||||||
2023-04-27 16:38:00 -0400 | 2023-04-27 | D | 20,627 | d | 0 | direct | ||||||||||
2023-04-27 16:38:00 -0400 | 2023-04-27 | D | 700 | $20.00 | d | 0 | direct | |||||||||
2023-04-27 16:32:08 -0400 | 2023-04-27 | D | 578,310 | $20.00 | d | 232,712 | direct | |||||||||
2023-04-27 16:32:08 -0400 | 2023-04-27 | D | 232,712 | $20.00 | d | 0 | direct | |||||||||
2023-04-27 16:36:17 -0400 | 2023-04-27 | D | 8,561 | $20.00 | d | 0 | direct | |||||||||
2023-04-27 16:33:56 -0400 | 2023-04-27 | D | 19,700 | d | 0 | direct | ||||||||||
2023-04-27 16:33:56 -0400 | 2023-04-27 | D | 3,153 | $20.00 | d | 0 | direct | |||||||||
2023-04-27 16:34:20 -0400 | 2023-04-27 | D | 103,719 | d | 0 | direct | ||||||||||
LAWLOR AUGUSTINE - Director by lawlor family trust |
2023-04-27 16:34:20 -0400 | 2023-04-27 | D | 25,318 | $20.00 | d | 0 | indirect | ||||||||
2023-04-27 16:34:20 -0400 | 2023-04-27 | D | 5,022 | $20.00 | d | 0 | direct | |||||||||
2023-04-27 16:35:38 -0400 | 2023-04-27 | D | 29,816 | d | 0 | direct | ||||||||||
2023-04-27 16:35:38 -0400 | 2023-04-27 | D | 12,411 | $20.00 | d | 0 | direct | |||||||||
2023-04-27 16:35:57 -0400 | 2023-04-27 | D | 81,881 | $20.00 | d | 32,503 | direct | |||||||||
2023-04-27 16:35:57 -0400 | 2023-04-27 | D | 32,503 | $20.00 | d | 0 | direct | |||||||||
2023-04-27 16:36:17 -0400 | 2023-04-27 | D | 75,659 | $20.00 | d | 8,561 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 22:15:04 UTC | 4.3902 | 0.4298 | 1200000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 21:45:04 UTC | 4.3902 | 0.4298 | 1200000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 21:15:04 UTC | 4.3902 | 0.4298 | 1200000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 20:45:04 UTC | 4.3902 | 0.4298 | 1200000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 20:15:05 UTC | 4.3902 | 0.4298 | 1200000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 19:45:04 UTC | 4.3902 | 0.4298 | 1200000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 19:15:04 UTC | 4.3902 | 0.4298 | 1200000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 18:45:03 UTC | 4.3902 | 0.4298 | 1200000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 18:15:04 UTC | 4.3902 | 0.4298 | 1200000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 17:45:04 UTC | 4.3902 | 0.4298 | 1200000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 17:15:04 UTC | 4.3902 | 0.4298 | 1300000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 16:45:04 UTC | 4.3902 | 0.4298 | 1300000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 16:15:04 UTC | 4.3902 | 0.4298 | 1700000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 15:45:04 UTC | 4.3902 | 0.4298 | 1700000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 15:15:03 UTC | 4.3902 | 0.4298 | 1300000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 14:45:03 UTC | 4.3902 | 0.4298 | 1400000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 14:15:04 UTC | 4.3902 | 0.4298 | 1400000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 13:45:04 UTC | 4.3902 | 0.4298 | 1300000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 13:15:04 UTC | 4.3902 | 0.4298 | 1700000 |
CARDIOVASCULAR SYSTEMS INC CSII | 2023-04-27 12:45:03 UTC | 4.3902 | 0.4298 | 1700000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Trust for Professional Managers- Convergence Market Neutral Fund | CSII | -3519.0 shares, $-114965.73 | 2020-08-31 | N-PORT |
FundVantage Trust- Gotham Enhanced Index Plus Fund | CSII | -41.0 shares, $-1443.61 | 2020-03-31 | N-PORT |
FundVantage Trust- Gotham Index Plus All-Cap Fund | CSII | -78.0 shares, $-2746.38 | 2020-03-31 | N-PORT |
Congress Person | Party | Chamber | Filing | Filing Date | Transaction Date | Security Type | Owner | Transaction | Amount | |
---|---|---|---|---|---|---|---|---|---|---|
![]() |
senator Tina Smith | democrat | Senate | Filing | 2023-04-19 | 2023-04-05 | SP | S | $50,001-$100,000 | |
![]() |
senator Tina Smith | democrat | Senate | Filing | 2023-04-19 | 2023-04-05 | SP | S | $50,001-$100,000 |